Want to see TSE:NARA full AI Analyst Report?
NARA Stock Chart & Stats
C$0.32
C$0.01(3.13%)
At close: 4:00 PM EDT
C$0.32
C$0.01(3.13%)
Day’s Range― - ―
52-Week RangeC$0.25 - C$2.57
Previous CloseN/A
Volume6.08K
Average Volume (3M)110.39K
Market Cap
C$5.06M
Enterprise ValueC$12.47
Total Cash (Recent Filing)C$40.85K
Total Debt (Recent Filing)C$482.87K
Price to Earnings (P/E)―
Beta0.60
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.21
Shares Outstanding14,046,870
10 Day Avg. Volume77,322
30 Day Avg. Volume110,395
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)-3.87
Price to Sales (P/S)0.00
P/FCF Ratio-4.51
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Scalable Software ModelOperating in the Software - Application sector implies a structurally scalable, low-marginal-cost business model. Over months this supports potential high operating leverage and margin expansion once product-market fit or monetization is achieved, benefiting long-term profitability.
Modest Absolute DebtReported debt of roughly $483k (TTM) is modest in absolute terms. A limited nominal debt burden reduces immediate interest and near-term refinancing pressure compared with heavily leveraged peers, providing some near-term flexibility while the company addresses cash burn.
Lower Systematic VolatilityA beta around 0.63 indicates lower systematic volatility versus the market. Structurally lower share-price volatility can help management plan financing and capital-allocation decisions with less risk of disorderly market moves complicating long-term strategic execution.
Bears Say
No RevenueThe company reports no revenue across periods while incurring recurring net losses. Without demonstrable sales or recurring revenue, the core business model remains unproven and the firm cannot demonstrate sustainable unit economics or path to self-funded growth.
Sustained Cash BurnOperating cash flow is structurally negative (~-$2.1M TTM) and free cash flow has been negative in every period. Persistent cash burn creates ongoing financing needs, increasing dilution or insolvency risk if capital markets tighten or funding terms worsen.
Negative Shareholders' EquityAccumulated losses have produced negative shareholders' equity, weakening the capital buffer. This reduces borrowing capacity, increases creditor priority risk, and limits strategic flexibility, heightening solvency concerns absent a clear turnaround or capital infusion.
PanGenomic Health, Inc. Class A News
NARA FAQ
What was PanGenomic Health, Inc. Class A’s price range in the past 12 months?
PanGenomic Health, Inc. Class A lowest stock price was C$0.25 and its highest was C$2.57 in the past 12 months.
What is PanGenomic Health, Inc. Class A’s market cap?
PanGenomic Health, Inc. Class A’s market cap is C$5.06M.
When is PanGenomic Health, Inc. Class A’s upcoming earnings report date?
PanGenomic Health, Inc. Class A’s upcoming earnings report date is Aug 27, 2026 which is in 20 days.
How were PanGenomic Health, Inc. Class A’s earnings last quarter?
Currently, no data Available
Is PanGenomic Health, Inc. Class A overvalued?
According to Wall Street analysts PanGenomic Health, Inc. Class A’s price is currently Overvalued.
Does PanGenomic Health, Inc. Class A pay dividends?
PanGenomic Health, Inc. Class A does not currently pay dividends.
What is PanGenomic Health, Inc. Class A’s EPS estimate?
PanGenomic Health, Inc. Class A’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PanGenomic Health, Inc. Class A have?
PanGenomic Health, Inc. Class A has 14,046,870 shares outstanding.
What happened to PanGenomic Health, Inc. Class A’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of PanGenomic Health, Inc. Class A?
Currently, no hedge funds are holding shares in TSE:NARA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
PanGenomic Health, Inc. Class A
Pangenomic Health Inc. is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments to support mental health. The company's mobile app, the Nara App, provides consumers with a knowledge base tailored to an individual's unique user profile. Its PlantGx Platform provides health practitioners with access to a consumer's Nara App data to assist them in optimizing the identification of appropriate natural remedies and monitoring a patient's prognosis.
Technical Analysis
Diagnos
―
nDatalyze Corp
―
Rocket Doctor AI
―
UniDoc Health Corp
―
DiagnaMed Holdings Corp.
―